BG Medicine scuttles IPO - again
December 17, 2010 by MassDevice staff
BG Medicine Inc. withdraws its second initial public offering after failing to price the deal.
BG Medicine Inc. scuttled its second initial public offering, having failed to set a price for the deal this week, nearly three years after it withdrew its first IPO.
The Waltham, Mass.-based diagnostics firm was expected to announce a price of between $13 and $15 per share this week for the 4.8 million share offering, but scrapped those plans, according to Dow Jones Newswires.
The most recent IPO was scaled back from plans BG announced in January for an $86.3 million offering. The company's shares were to have traded on the NASDAQ exchange under the BGMD symbol.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
Navigation
NEWS
Chest docs include Covidien's superDimension lung biopsy device in guidelines
The lung biopsy device acquired by Covidien in its superDimension acquisition is included in new...
Medtronic hits 52-week high on Q4, FY2013 results
Investors sent Medtronic shares to a 52-week high yesterday after the world's largest medical device...
MassDevice.com +3 | The top 3 med-tech stories for May 21, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Maquet acquires LAAx and its TigerPaw II heart implant
Getinge Group's medical device subsidiary Maquet Cardiovascular buys LAAx and its TigerPaw heart...
EuroPCR: Medtronic's renal denervation looks good in the real world
Medical device giant Medtronic unveils a 1st look from its global Symplicity renal denervation...
